Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuyler, M.
Right arrow Articles by Malone, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuyler, M.
Right arrow Articles by Malone, J. D.
(Chest. 2003;123:1769-1770.)
© 2003 American College of Chest Physicians

Link Between Anthrax Immunization and Hypersensitivity Pneumonitis?

Mark Schuyler, MD, FCCP

University of New Mexico School of Medicine Albuquerque, NM

Correspondence to: Mark Schuyler, MD, FCCP, Professor of Medicine, University of New Mexico School of Medicine, Albuquerque VA Medical Center, 1501 San Pedro, SE, Albuquerque, NM 87108

To the Editor:

The recent case report by Timmer et al,1 in the August 2002 issue of CHEST, purports to describe hypersensitivity pneumonitis (HP) caused by anthrax immunization. I must respectively disagree with the hypothesis that anthrax vaccination caused the chronic pulmonary illness (bronchiolitis obliterans with organizing pneumonia [BOOP] caused by HP) described in this patient, although he most likely did suffer from HP.

IgE-mediated phenomena, such as urticaria that the patient experienced shortly after the immunization, is not a feature of HP. As the authors note, the patient was exposed to a very well- described source of antigen that does cause HP, a cockatiel at home. Indeed, she had evidence of sensitization to birds, ie, positive serum precipitins to cockatiel droppings and feathers.

The improvement of the patient after he was treated with corticosteroids, despite the continued presence of the cockatiel, is not strong evidence that the cockatiel did not cause his disease. The relationship between exposure and illness in HP is not linear.

It is important that there be very substantial evidence of cause and effect when a new cause of HP is described, in this instance, anthrax vaccination causing HP. This evidence should include conclusive evidence linking a putative etiologic agent with the disease. This should include repetitive episodes of deterioration after more than one exposure to the responsible agent and the lack of exposure to any known cause of HP. Clearly, these criteria are not satisfied by this case report.2

I believe that the patient had an immediate IgE-mediated adverse event after the anthrax vaccination. During the evaluation of this event, his pre-existing BOOP/HP due to cockatiel exposure became evident. In view of the possible future importance of anthrax immunization in our nation, it is important that we be very sure that a particular adverse event was caused by this immunization before reporting it in the medical literature.

References

  1. Timmer, SJ, Amundson, DE, Malone, JD (2001) Hypersensitivity pneumonitis following anthrax vaccination. Chest 122,741-745
  2. Schulyer, M, Cormier, Y Diagnosis of hypersensitivity pneumonitis. Chest 1997;111,534-536[Free Full Text]

Dennis E. Amundson, MD, CAPT, MC, USN, FCCP and John D. Malone, MD, CAPT, MC, USN

San Diego, CA

Correspondence to: CAPT D.E. Amundson, MD, MC, USN, FCCP, 751 Rosecrans St, San Diego, CA 92106; e-mail: deamundson{at}nmcsd.med.navy.mil

To the Editor:

Thank you for your insightful comments. Publication was delayed for nearly a year while a variety of specialists from the National Institutes of Health, Armed Forces Institute of Pathology, and the Air Force and Navy Surgeon General’s office reviewed the case to confirm our conclusions. Additionally, our patient’s status was reconfirmed with a comprehensive battery of sophisticated testing related to his bird exposure history. The components of the case suggesting that the anthrax vaccination was the most likely cause of his hypersensitivity pneumonitis (HP) and bronchiolitis obliterans with organizing pneumonia (BOOP) are as follows.

First, the subsequent temporal sequence of the development of his symptoms and lung disease was believed to be more typical of an induced lung reaction. Two allergy experts also recognized the initial skin reaction as atypical for HP, and the patient was initially seen in allergy consultation for the skin reaction. An IgE event was postulated at that time.

Second, the high-resolution CT demonstrating well-defined peribronchiolar nodules within the ground-glass opacities, coupled with the transbronchial lung biopsy showing the (probably heterogenous) fibroblastic plugs indicated a lung reaction that includes a BOOP component. This pattern is more consistent with a chemical induction than with an organic inhalational stimulus, which is more typically associated with ill-defined nodules (rarely) and patchy airspace consolidation, usually in the mid-lung zones.1

In 1-year follow-up of the patient (off steroids for 8 months), specific immunologic testing results for this particular cockatiel were negative. Moreover, the patient has continued to live with the bird without further symptoms. The clinical heterogeneity of HP, especially with steroid therapy, is certainly recognized. We feel that the temporal and pathologic association has biologic plausibility. This case was also reported to the Vaccine Adverse Event Reporting System and was classified as having "likely correlation" with anthrax vaccination by this expert panel.

Finally, as military physicians, we remain advocates for this safe and effective vaccine, especially in the current world situation. We reported the case to ensure complete disclosure and to enhance management of any further cases.

References

  1. Webb, RW, Müller, NL, Naidich, DP High resolution CT of the lung. 2nd ed. 1996 Lippincott, Williams, and Wilkins. Baltimore, MD:




This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuyler, M.
Right arrow Articles by Malone, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuyler, M.
Right arrow Articles by Malone, J. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS